Receptor-mediated local fine-tuning by noradrenergic innervation of neuroendocrine and immune systems

Annals of the New York Academy of Sciences

Volumn 851, Issue , 1998, Pages 388-396

  Vizi, E S ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUCOCORTICOID; RECEPTOR;

ADRENAL CORTEX; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CORTICOTROPIN RELEASE; HYPOTHALAMUS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; NEUROENDOCRINE SYSTEM; NORADRENERGIC SYSTEM;

EID: 0031825874     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09012.x     Document Type: Conference Paper

References (60)

1. BERKENBOSCH, F. B., J. VAN OERS, A. DEL REY, F. J. H. TILDERS & H. O. BESEDOVSKY. 1987. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238: 524-526.
2. BESEDOVSKY, H. O., A. DEL REY, E. SORKIN, M. DA PRADA, R. BURRI & C. HONEGGER. 1983. The immune response evokes changes in brain noradrenergic neurons. Science 221: 564-566.
3. BESEDOVSKY, H. O., A. DEL REY, E. SORKIN & C. A. DINARELLO. 1986. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233: 652-654.
4. CHROUSOS, G. P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332: 1351-1352.
5. WILDER, R. C. 1996. Adrenal and gonadal steroid hormone deficiancy in the etiopathogenesis of rheumatoid arthritis. J. Rheumatol. Suppl. 44: 23-25.
6. MADDEN, K. S., V. M. SANDERS & D. L. FELTEN. 1995. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmac. Toxicol. 35: 417-448.
7. BESEDOVSKY, H. O. & A. DEL REY. 1996. Immune-neuro-endocrine interactions: facts and hypothesis. Endocrine Rev. 17: 64-102.
8. SZABÓ, C. S. 1996. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull. 41 (3): 131-141.
9. FELTEN, D. L., S. Y. FELTEN, D. L. BELLINGER, S. L. CARLSON, K. D. ACKERMAN, K. S. MADDEN, J. A. OLSCHOWSKYA & S. LIVNAT. 1987. Noradrenergic sympathetic neural interactions with the immune system. Immunol. Rev. 100: 225-260.
10. BENCSICS, A., I. J. ELENKOV & E. S. VIZI. 1997. Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-α production in vivo. Involvement of the sympathetic nervous system. J. Immunol. 73:1-6.
11. MCCARTHY PASTORES, S., G. HASKO, E. S. VIZI & V. KVETAN. 1996. Cytokine production and its manipulation by vasoactive drugs. N. Horiz. 4:252-264.
12. DUNN, A. J. & J. WANG. 1995. Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 2:319-328.
13. PAPANICOLAOU, D. A., J. S. PETRIDES, C. TSIGOS, S. BINA, K. T. KALOGERAS, R. WILDER, P. W. GOLD, P. A. DEUSTER & G. P. CHROUSOS. 1996. Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines. Am. J. Physiol. 271: E601-605.
14. PITOSSI, E, A. DEL REY, A. KABIERSCH & H. BESEDOVSKY. 1997. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J. Neurosci. Res. 48: s287-298.
15. VIZI, E. S. 1984. Non-synaptic Interactions between Neurons: Modulation of Neurochemical Transmission. Pharmacological and Clinical Aspects. John Wiley. Chichester/New York.
16. VIZI, E. S. & E. LÁBOS. 1991. Nonsynaptic interactions at presynaptic level. Progr. Neurobiol. 37: 145-163.
17. SMAGIN, G. N., A. H. SWIERGIEL & A. J. DUNN. 1996. Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalmus: Comparison with plasma conrticosterone. 21: 83-93.
18. LAVICKY, J. & A. J. DUNN. 1995. Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis. J. Neurosci. Res. 40: 407-413.
19. SMAGIN, G. N., J. ZHOU, R. B. S. HARRIS & D. H. RYAN. 1997. CRF receptor antagonist attenuates immobilization stress-induced norepinephrine release in the prefrontal cortex in rats. Brain Res. Bull. 42: 431-434.
20. GAYLE, D. S. E. ILYIN & C. R. PLATA-SLAMÁN. 1997. Interleukin-1 receptor type I mRNA levels in brain regions from male and female rats. Brain Res. Bull. 42: 463-467.
21. BRET-DIBAT, J.-L., C. CREMINON J.-Y. COURAUD, K. W. KELLEY, R. DANTZER & S. KENT. 1997. Systemic capsaicin pretreatment fails to block the decrease in food-motivated behavior induced by lipopolysaccharide and interleukin-1β. Brain Res. Bull. 42: 443-449.
22. JAMES, E. G., D. D. KENDAL & M. D. KENDAL. 1996. Peripheral and central neural mechanisms for immune regulation through the innervation of immune effector sites. In J. A. Marsh & M.D. Kendall, Ed. 103-127. The Physiology of Immunity. CRC Press.
23. VIZI, E. S., L. G. HÁRSING, JR., I. ZIMANYI & G. GAAL. 1985. Release and turnover of noradrenaline in isolated median eminence: Lack of negative feedback modulation. Neuroscience 16: 907-916.
24. ELENKOV, I. J., K. KOVÁCS, E. DUDA, E. STARK & E. S. VIZI. 1992. Presynaptic inhibitory effect of TNF-α on the release of noradrenaline in isolated median eminence. J. Neuroimmunol. 41: 117-120.
25. SOLIVEN, B. & J. ALBERT. 1992. Tumor necrosis factor modulates the inactivation of catecholamine secretion in cultured sympathetic neurons. J Neurochem. 58: 1073-1078.
26. ANTONI, F. A., G. FINK & W. J. SHEWARD. 1990. Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: A marked reduction in the concentration of corticotrophin-releasing factor-41, but no change in vasopressin. J. Endocrinol. 125: 175-183.
27. MAKARA, G. B. 1992. The relative importance of hypothalamic neurons containing corticotropin-releasing factor or vasopressin in the regulation of adrenocorticotropic hormone secretion. In D. J. Chadwick J. Marsh, Ed. 43-53. Functional Anatomy of the Neuroendocrine Hypothalamus. CIBA Foundation Symposium 168. John Wiley. Chichester.
28. ELENKOV, I. J., K. KOCÁCS, L. BERTÓK, & E. S. VIZI. 1992. Lipopolysaccharide is able to by pass corticotrophin-releasing factor in affecting plasma ACTH and corticosterone levels: evidence from rats with lesion of the paraventricular nucleus. J. Endocrinol. 133: 231-236.
29. 2-adrenergic drugs on ACTH secretion. Neuroendocrinology 57: 346-350.
30. 2-adrenoceptors on plasma levels of tumour necrosis factor-α, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J. Endocrinol. 144: 457-462.
31. HANISCH, U. K., D. SETO & R. QUIRION. 1993. Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J. Neurosci. 13: 3368-3374.
32. BOGNAR, I. T., S. A. ALBRECHT, M. FARASATY, E. SCHMITT, G. SEIDEL & H. FUDER. 1994. Effects of human recombinant interleukins on stimulation-evoked noradrenaline overflow from the rat perfused spleen. Naunyn Schmiedebergs Arch. Pharmacol. 349: 497-502.
33. FELTEN, D. L., K. D. ACKERMAN, S. J. WIEGAND & S. Y. FELTEN. 1987. Noradrenergic sympathetic innervation of the spleen. I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J. Neurosci. Res. 18: 28-36.
34. VIZI, E. S., I. E. TOTH, K. SZ. SZALAY, K. WINDISCH, E. ORSÓ, D. SZABÓ & G. P. VINSON. 1992. Catecholamines released from local adrenergic axon terminals are possibly involved in fine tuning of steroid secretion from zona glomerulosa cells: Functional and morphological evidence. J. Endocrinol. 135: 551-556.
35. VIZI, E. S., I. E. TOTH, E. ORSÓ, K. SZ. SZALAY, D. SZABÓ, M. BARANYI, & G. P. VLNSON. 1993. Dopamine is taken up from the circulation by, and released from, local noradrenergic varicose axon terminals in zona glomerulosa of the rat: A neurochemical and immunocytochemical study. J. Endocrinol. 139: 213-226.
36. VIZI, E. S., E. ORSÓ, G. P. VINSON & K. SZ. SZALAY. 1996. Local fine tuning by noradrenalin and dopamine of steroid release from glomerulosa cells boosted by ACTH. In Adrenal Glands, Vascular System and Hypertension. G. P. Vinson & D. C. Anderson, Eds: 293-302.
37. ELENKOV, I. J. & E. S. VIZI. 1991. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology 12: 1319-1324.
38. VIZI, E. S., E. ORSÓ, O. N. OSIPENKO, G. HASKÓ & I. ELENKOV. 1995. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the symphatetic nervous system and thymocytes. Neuroscience 68: 1263-1276.
39. HASKÓ, G., I. J ELENKOV & E. S. VIZI. 1995. Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus. Immunol. Lett. 47: 133-137.
40. ABRASS, C. K., S. W. O'CONNOR, P. J. SCARTACE & I. B. ABRASS. 1985. Characterization of the β-adrenergic receptor of the rat peritoneal macrophage. J. Immunol 135: 1338-1341.
41. SPENGLER, R. N., R. M. ALLEN, D. G. REMICK, R. M. STRIKTER & S. L. KUNKEL. 1990. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145: 1430-1434.
42. ELENKOV, I. J., D. A. PAPANICOLAOU, R. L. WILDER & G. P. CHROUSOS. 1996. Modulatory effects of glucocortkoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc. Ass. Am. Phys. 108: (5): 1-8.
43. CHOU, R. C., M. W. STINSON, B. K. NOBLE & R. N. SPENGLER. 1996. β-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-α production from rats with experimental arthritis. J. Neuroimmunol. 67: 7-16.
44. CHORE, R. C., M. W. STINSON, B. K. NOBLE & R. N. SPENGLER. 1996. β-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-α production from rats with experimental arthritis. J. Neuroimmunol. 67: 7-16.
45. SPENGLER, R. N., S. W. CHENSUE, D. A. GIACHERIO, N. BLENK & S. L. KUNKEL. 1994. Endogenous norepinephrine regulates rumor necrosis factor-α production from macrophages in vitro. J. Immunol. 152: 3024-3031.
46. VAN DER POLL, T., J. JANSEN, E. ENDERT, H. P. SAUERWEIN & S. J. VAN DEVENTER. 1994. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect. Immun. 62: 2046-2050.
47. SZABÓ, C., G. HASKÓ, B. ZINGARRELLI, Z. NÉMETH, A. L. SALZMAN, V. KVETAN, S. MCCARTHY PASTURES & E. S. VIZI. 1997. Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90: 95-100.
48. IGNATOWSKI, T. A. & R. N. SPENGLER. 1995. Regulation of macrophage derived tumor necrosis factor (TNF) production by modification of adrenergic receptor sensitivity. J. Neuroimmunol. 61: 61-70.
49. SEVERN, A., N. T. RAPSON, C. A. HUNTER & F. Y. LIEW. 1992. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J. Immunol. 148: 3441-3445.
50. CHELMICKA-SCHORR, E., M. E. CHECINSKI & B. G. W. ARNASON. 1988. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 17: 347-350.
51. KARASZEWSKI, J. W., A. T. REDER, R. MASELLI, M. BROWN & B. G. W. ARNASON. 1990. Sympathetic skin responses are decreased and lymphocyte β-adrenergic receptors are increased in progressive multiple sclerosis. Ann. Neurol. 27: 366-372.
52. ELENKOV, I. J., GY. HASKÓ, K, J. KOVÁCS & E. S. VIZI. 1995. Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and α-adrenergic drugs in mice. J. Neuroimmunol. 61: 123-131.
53. SUBERVILLE, S., A. BELLOCQ, B. FOUQUERAY, C. PHILIPPE, O. LANTZ, J. PEREZ & L. BAUD. 1996. Regulation of interleukin-10 production by β-adrenergic agonists. Eur. J. Immunol. 26: 2601-2605.
54. HU, X., E. A. GOLDMUNTZ & C. F. BROSNAN. 1991. The effect of norepinephrine on endotoxin-mediated macrophage activation. J. Neuroimmunol. 31: 35-42.
55. FESSLER H. E., L. OTTERBEIN, H. S. CHUNG & A. M. K. CHOI. 1996. Alpha-2 adrenoceptor blockade protects rats against lipopolysaccharide. Am. J. Respir. Crit. Care Med. 154: 1689-1693.
56. VIZI, E. S., I. E. TOTH, K. SZ. SZALAY, K. WLNTOISCH, E. OKSO, D. SZABÓ & G. P. VINSON. 1992. Catecholamines released from local adrenergic axon terminals are possibly involved in fine tuning of steroid secretion from zona glomerulosa cells: Functional and morphological evidence. J. Endocrinol. 135: 551-556.
57. KVETŇANSKÝ, R., I. ARMANDO, V. K. WEISE, C. HOLMES, K. FUKUHARA, A. DEKA-STAROSTA, I. J. KOPIN & D. S. GOLDSTEIN. 1992. Plasma dopa responses during stress: Dependence on sympathoneural activity and tyrosine hydroxylation. J. Pharmacol. Exp. Ther. 261: 899-909.
58. HASKÓ, GY, CS. SZABÓ, H. Z. NÉMETH, V. KVETAN, S. M. PASTORES & E. S. Vizi. 1996. Adenosine receptor agonists differentially regulate IL-10 TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157: 4634-4640.
59. HASKÓ, G., C. SZABÓ, K. MERKEL, A. BENCSICS, B. ZINGARELU, V. KVETAN & E. S. VIZI. 1996. Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol. Lett. 49: 143-147.
60. OSIPENKO, O. N., P. VÁRNAI, A. MIKE, A, SPAT & E. S. VIZI. 1994. Dopamine blocks T-type calcium channels in cultured rat adrenal glomerulosa cells. Endocrinology 134: 511-514.